Molecular Genetics and Genetic Diseases
A section of Biomedicines (ISSN 2227-9059).
Section Information
The section “Molecular Genetics and Genetic Diseases” covers the basic and translational aspects of human genetic diseases and genomics research, from fundamental molecular investigation to preclinical animal models. In particular, this section aims to facilitate the rapid publication of innovative research encompassing the genetic basis of human health and disease, as well as the treatment of genetic disorders, and heritable or acquired cancers. We welcome submissions that apply new and emerging technologies in the fields of genomics, transcriptomics and bioinformatic tools to advance knowledge in human genetic diseases.
Topics within the scope of this section include, but are not limited to:
- Chromosome organization, structure, and function; chromatin remodeling and dynamics, chromosomal maintenance elements;
- DNA replication, repair, recombination, mobile DNA, mitochondrial DNA;
- DNA methylation, histone modification, histone code;
- RNA biology, transcription and splicing, coding and non-coding RNA analysis, RNA localization, translation and catalysis by RNA;
- Post-transcriptional regulation of gene expression;
- Genetic toxicology and environmental mutagenesis;
- Genetics of monogenic diseases and complex diseases; genotype–phenotype relationships;
- Precision medicine; pharmacogenetics and pharmacogenomics;
- Targeted genome editing; gene therapy and delivery systems; genetically-engineered cell therapy
- RNA and small nucleic acid-based therapeutics;
- Genetic testing and molecular diagnostics; biomarker development and application; genome-wide association studies;
- Epigenetic therapy; cancer immunotherapy;
- Developmental genetics; epigenetics and epigenomics.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Genetic Research and Molecular Diagnostics for Hematological Diseases (Deadline: 31 August 2026)
- Bioinformatic Insights into Cancer Biology: Transforming Data into Discovery (Deadline: 31 August 2026)
- Bioinformatic Insight into Genetics (Deadline: 30 September 2026)
- Advances in Hereditary Hearing Loss—Genetics, Diagnosis, and Options of Treatment (Deadline: 30 September 2026)
- Unveiling the Genetic Architecture of Complex and Common Diseases (Deadline: 23 October 2026)
- Pharmacogenomics and Drug Metabolism: From Cytochrome P450 to Emerging Enzymatic Pathways (Deadline: 30 October 2026)
- Muscular Dystrophy: From Mechanisms to Therapeutic Approaches (Deadline: 30 November 2026)
- Genome Engineering Technologies for Diseases (Deadline: 31 December 2026)
- Cancer Genetics: Bench-to-Bedside Advances (Deadline: 31 December 2026)
- Genetic Research into Human Reproduction (Deadline: 31 December 2026)
- Novel Insight into Human Reproductive Medicines (Deadline: 30 January 2027)
- Genetic and Epigenetic Research on Kidney Diseases (Deadline: 20 February 2027)
- Ophthalmic Genetics: Unraveling the Genomics of Eye Disorders—2nd Edition (Deadline: 28 February 2027)
- DNA Methylation in Ageing and Disease: Biomarkers, Mechanisms and Translational Applications (Deadline: 28 February 2027)
- Translational Transcriptomics in Health and Disease (Deadline: 28 February 2027)
- Role of DNA Methylation in Human Health and Diseases (Deadline: 28 February 2027)
- Hereditary Diseases: Insights from Genetic Perspectives (Deadline: 28 February 2027)
- Current Status and Future Directions of Molecular Genetics and Genetic Diseases (Deadline: 31 March 2027)
- Bioinformatics Analysis of RNA for Human Health and Disease—2nd Edition (Deadline: 30 April 2027)
- Genetic Research of Hearing Loss (Deadline: 30 April 2027)
- Technologies and Applications of Genome Editing in Biomedicine (Deadline: 31 May 2027)
